title: Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
authors.affiliation: Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto ON. shinya.ito@sickkids.ca
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Tanaka
authors.forename: Ken
authors.initials: K
authors.lastname: Nakajima
authors.forename: Atsuko
authors.initials: A
authors.lastname: Murashima
authors.forename: Facundo
authors.initials: F
authors.lastname: Garcia-Bournissen
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
authors.forename: Shinya
authors.initials: S
authors.lastname: Ito
mesh_terms: D001942:Breast Feeding; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy* / Q000201:enzymology / Q000821:virology; D007774:Lactation / Q000187:drug effects; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D053139:Oseltamivir / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000201:enzymology; D016896:Treatment Outcome; D014765:Viral Vaccines / Q000627:therapeutic use*; D053243:Zanamivir / Q000627:therapeutic use
chemical_list: D004791:Enzyme Inhibitors; D014765:Viral Vaccines; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir